Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Francis S. Willard(Eli Lilly (United States)), Kyle W. Sloop(Eli Lilly (United States))
Cited by 468
Related Papers
Rgs1 regulates multiple Gα subunits in Magnaporthe pathogenesis, asexual growth and thigmotropism
|The EMBO Journal|2007|151
Uncoupling Protein 3 (UCP3) Stimulates Glucose Uptake in Muscle Cells through a Phosphoinositide 3-Kinase-dependent Mechanism
|Journal of Biological Chemistry|2001|86